NCT07851324Not yet recruiting
Stromal Desmoplastic Reaction as a Predictive Factor for Lymph Node Metastasis in Medullary Thyroid Cancer
Source: ClinicalTrials.gov · Last updated 1 Oct 2026
Brief summary (registry, in English)
This is a prospective multicenter observational study on medullary thyroid cancer , aiming to investigate the correlation of stromal desmoplastic reaction with tumor aggressiveness.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 74 (estimated)
- First submitted
- 20 Sept 2026
- Start date
- 30 Sept 2026
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Aristotle University Of Thessaloniki
- Diseases
- Thyroid cancer
- NCT number
- NCT07851324
What you commit to
- Study type: Observational
- Planned participants: 74
- From 30 Sept 2026 to the primary completion date, 30 Jun 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hereditary medullary thyroid cancer cases
Age
- Age \< 18 years
Other
- Patients that do not undergo central or lateral lymph node dissection
- Patient unwillingness to participate in this study
- Incomplete follow-up
- Patient is participating in another clinical trial which may affect this study's outcomes
Who the study is looking for
- Patients who underwent thyroidectomy for medullary thyroid cancer (total thyroidectomy) +/- central/lateral neck dissection
- Sporadic medullary thyroid cancer
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.